Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.
Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.
<iframe src="https://hindustansphere.com/embed/cluster/e2d66a130cddb2637da1943edfa489899166f719" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="ICICI Life Insurance shares: Despite 34% slump in 2026, Religare sees 42% upside post Q2 results | Here's why"></iframe>
